TerminatedNot applicableNCT00681512

The Effect of Berries on Lung Cancer Tumors

The purpose of this study is to determine how berries affect cancer tumors in patients with non-small cell lung cancer.

Checked against the public recordLast updated Feb 6, 2018 · Source: ClinicalTrials.gov

StatusTerminated
PhaseNot applicable
U.S. locations1
SponsorUniversity of Louisville
01
Study overview

What this study is about

Purpose
Basic Science
Study type
Interventional
Phase
Not applicable
Sponsor
University of Louisville
Interventions being studied
Dietary Supplement: berry powder
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

Inclusion Criteria (lung cancer survivors): * men treated for lung cancer, women treated for lung cancer and with no child-bearing potential (hysterectomy, tubal ligation, post-menopausal women) Exclusion Criteria (lung cancer survivors): * women who are on hormone replacement therapy * women who are pregnant, or planning for pregnancy * history of lung transplant * prison inmate * inability to take oral medication or food * known or suspected allergy to berries or berry products * HIV patients Inclusion Criteria (volunteers): * adult men, adult women with no child bearing potential (hysterectomy, tubal ligation, post-menopausal women) Exclusion Criteria (volunteers): * women who are on hormone replacement therapy * women who are pregnant, or planning for pregnancy * history of lung transplant * prison inmate * inability to take oral medication or food * known or suspected allergy to berries or berry products * HIV patients

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • James Graham Brown Cancer CenterLouisville, Kentucky

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Feb 6, 2018. Always confirm current availability with the study team.

View original record ↗